Opendata, web and dolomites

DOCTRINA

A Unique Virtual Environment where Healthcare Professionals Can Find the Support that They Need for an Adequate Use of Pharmaceutical Products

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DOCTRINA project word cloud

Explore the words cloud of the DOCTRINA project. It provides you a very rough idea of what is the project "DOCTRINA" about.

for    model    companies    lack    proper    costly    schedule    regime    version    created    pharmacists    visits    fail    prescription    received    sales    incurring    launch    650    givers    gap    education    bridge    right    healthcare    anytime    50    businesses    patient    perspectives    pay    turn    barrier    alternative    providers    pharma    educational    doctors    free    altogether    revenues    adherence    financial    properly    relieve    24    company    prescribed    doctrina    pharmaceutical    despite    materials    platform    acceptance    securing    busy    market    billion    adhere    learners    preliminary    consuming    incurred    commercial    extremely    customized    125    guidance    acknowledged    communication    time    global    patients    cumulative    back    relied    poor    professionals    agents    helping    correct    begins    care    inefficiency    huge    community    inefficient    anywhere    communicate    feasibility    difficult    enrolling    ict    inadequate    hold   

Project "DOCTRINA" data sheet

The following table provides information about the project.

Coordinator
DOCTRINA, IZOBRAZEVANJE, DOO 

Organization address
address: VOJKOVA CESTA 63
city: LJUBLJANA
postcode: 1000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Slovenia [SI]
 Project website http://en.doctrina.biz/pharmacists
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2017-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DOCTRINA, IZOBRAZEVANJE, DOO SI (LJUBLJANA) coordinator 50˙000.00

Map

 Project objective

For pharmaceutical products to work effectively, they need to be used properly. In Europe, 50% of patients fail to adhere to the prescribed regime, incurring in € 125 billion costs. Poor patient adherence is often the result of poor management at the practice level. Indeed, the correct use of pharma products begins with the prescription by doctors and proper guidance from pharmacists. Therefore, it is important that pharma companies provide these professionals with the education they need, anywhere and anytime. Pharma companies have traditionally relied on sales representatives and agents that pay visits to healthcare professionals. However, this method is time consuming, costly, extremely inefficient and difficult to schedule with the busy healthcare professionals. Importantly, professionals lack the means to communicate back with the pharma company. Despite this acknowledged inefficiency, agents are still the best alternative available right now in the market. In response, we have created DOCTRINA, a unique and cost-effective ICT platform through which pharma companies will be able to maintain 24/7 communication with healthcare professionals to provide them customized educational materials. While learners experience barrier-free communication and support, pharma companies improve their businesses and product management. Since our preliminary version of the platform received high acceptance from end-users, we now aim to take the next step and scale up our model to hold a global community of users. Thus, the Feasibility Study planned in Phase 1 has the main objective of securing this project from all technical, commercial and financial perspectives. Altogether, our platform will bridge the existing gap between pharma providers and care givers, helping to relieve the huge impact incurred by the inadequate use of pharma products. In turn, DOCTRINA will provide us estimated cumulative revenues of €30 M after enrolling 650,000 users within five years from market launch

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DOCTRINA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DOCTRINA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

OE Scan (2018)

A next generation diagnostic device that effectively screens for breast cancer in all tissue types, without the use of ionising radiation

Read More  

Radiation detector (2018)

Novel radioactive radiation technology feasibility verification

Read More  

Leaf Line (2018)

The First Global Ground Station Network to Fully Exploit Microsatellites Data

Read More